NDAORALSYRUP
Approved
Dec 1980
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 4d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Lithium citrate is an oral syrup formulation of lithium, a small-molecule mood stabilizer used primarily in psychiatric treatment. It works by altering neurotransmitter activity in the brain, though its exact mechanism remains incompletely understood. This generic product has been a cornerstone therapy for decades.
$0.004BPart D
LOE ApproachingMature generic product with minimal Part D penetration and modest commercial footprint; limited team expansion expected as lifecycle winds down.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on lithium citrate at Hikma offers stable, legacy-product experience in generic psychiatry but minimal growth trajectory or innovation exposure. Roles focus on maintaining market share, optimizing manufacturing, and compliance rather than product advancement.
Generic Brand ManagerField Sales Representative
Worked on LITHIUM CITRATE at Hikma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.